Inventor · disambiguated record
Kimberly Drenser
Also filed as: DRENSER KIMBERLY · DRENSER KIMBERLY ALYSON
12 granted patents·5 pending applications·55 citations·filing 1998–2021
85Inventor score
Files withRETINAL SOLUTIONS LLC10DRENSER KIMBERLY2TRESE MICHAEL T2PARK CARL HYUNSUK1RETINAL SOLUTION LLC1
Top patents by PatentIndex Score
17 records- 0184US9114078B2Methods and compositions for genetic and retinal diseaseDRENSER KIMBERLY·Filed 2009·Granted Aug 25, 2015·7 cites·11 claims
- 0281US10669321B2Retinal capillary regeneration with synthetic norrin proteinRETINAL SOLUTIONS LLC·Filed 2018·Granted Jun 2, 2020·1 cites·9 claims
- 0379US6225291B1Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseasesUNIV FLORIDA·Filed 1998·Granted May 1, 2001·45 cites·62 claims
- 0469US10202429B2Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edemaRETINAL SOLUTIONS LLC·Filed 2015·Granted Feb 12, 2019·1 cites·13 claims
- 0568US10206978B2Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edemaRETINAL SOLUTIONS LLC·Filed 2015·Granted Feb 19, 2019·1 cites·9 claims
- 0661US11198714B2Synthetic truncated norrin proteinRETINAL SOLUTIONS LLC·Filed 2020·Granted Dec 14, 2021·0 cites·10 claims
- 0758US10799557B2Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edemaRETINAL SOLUTIONS LLC·Filed 2018·Granted Oct 13, 2020·0 cites·14 claims
- 0857US10703787B2Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edemaRETINAL SOLUTIONS LLC·Filed 2018·Granted Jul 7, 2020·0 cites·13 claims
- 0955US9504649B2Method and compositions for genetic and retinal diseaseRETINAL SOLUTIONS LLC·Filed 2015·Granted Nov 29, 2016·0 cites·8 claims
- 1054US2010211408A1Systems and methods for generating medical diagnosesPARK CARL HYUNSUK·Filed 2009·Application pending·0 cites
- 1153US2023126239A1Norrin regulation of plasmalemma vesicle-associated protein and use to treat macular degenerationRETINAL SOLUTION LLC·Filed 2021·Application pending·0 cites
- 1252US2024000890A1Neural regeneration with synthetic protein administrationRETINAL SOLUTIONS LLC·Filed 2021·Application pending·0 cites
- 1350US11041863B2Frizzled-4 mutation indicator of retinopathy and intrauterine growth restrictionRETINAL SOLUTIONS LLC·Filed 2017·Granted Jun 22, 2021·0 cites·7 claims
- 1447US2016022769A1Compostions and methods for treating retinal diseaseTRESE MICHAEL T·Filed 2013·Application pending·0 cites
- 1545US12485158B2Norrin induced expression of genes and use thereof to treat diseaseRETINAL SOLUTIONS LLC·Filed 2018·Granted Dec 2, 2025·0 cites·10 claims
- 1638US9622657B2Automated system for measurement of zone 1 in assessment of severity of retinopathy of prematurityTRESE MICHAEL T·Filed 2015·Granted Apr 18, 2017·0 cites·14 claims
- 1730US2012282230A1Methods and compositions for diagnosis and treatment of genetic and retinal diseaseDRENSER KIMBERLY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kimberly Drenser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →